Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for R (Q79193931)
Jump to navigation
Jump to search
scientific article published on 04 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for R |
scientific article published on 04 October 2006 |
Statements
Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group (English)
C J A Punt
S Suciu
M A Gore
J Koller
W H J Kruit
J Thomas
P Patel
D Lienard
A M M Eggermont